ExLibris header image
SFX Logo
Title: A novel reporter system for neutralizing and enhancing antibody assay against dengue virus
Source:

Bmc Microbiology [1471-2180] yr:2014


Collapse list of basic services Basic
Full text
Full text available via DOAJ Directory of Open Access Journals
GO
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Li, X.-Q. Q. "Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design." Journal of general virology 94.Pt 10 (2013): 2191-2201. Link to SFX for this item
2. Screaton, G. "The pathogenesis of dengue." Current opinion in infectious diseases 26.3 (2013): 284-289. Link to SFX for this item
3. Che, B. "Evaluation and analysis of dengue virus enhancing and neutralizing activities using simple high-throughput assays." Applied microbiology and biotechnology 97.14 (2013): 6503-6511. Link to Full Text for this item Link to SFX for this item
4. Gupta, B. "Fight against dengue in India: progresses and challenges." Parasitology research 112.4 (2013): 1367-1378. Link to SFX for this item
5. Arora, U. "Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice." Vaccine 31.6 (2012): 873-878. Link to SFX for this item
6. Humphreys, Julia m. "Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys." Vaccine 28.15 (2010): 2705-2715. Link to SFX for this item
7. Green, A. "Immunopathological mechanisms in dengue and dengue hemorrhagic fever." Current opinion in infectious diseases 19.5 (2006): 429-36. Link to SFX for this item
8. Lu, H. "Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in mice." Molecular immunology 54.2 (2013): 109-14. Link to SFX for this item
9. Whitehorn, J. "The pathogenesis of dengue." Vaccine 29.42 (2011): 7221-7228. Link to SFX for this item
10. Macias, M. "Safety and Immunogenicity of an Investigational Fully Liquid Hexavalent DTaP-IPV-Hep B-PRP-T Vaccine at Two, Four and Six Months of Age Compared With Licensed Vaccines in Latin America." The Pediatric infectious disease journal 31.8 (2012): 1102-1109. Link to SFX for this item
11. "Mosquito (Diptera: Culicidae) Habitat Surveillance by Android Mobile Devices in Guangzhou, China." Insects 7.4: 79-79. Link to SFX for this item
12. Khetarpal, N. "Dengue-specific subviral nanoparticles: design, creation and characterization." Journal of Nanobiotechnology 11.1 (2013): 15-. Link to Full Text for this item Link to SFX for this item
13. Liang, G. "High incidence of Japanese encephalitis, southern China." Emerging infectious diseases 19.4 (2013): 672-673. Link to Full Text for this item Link to SFX for this item
14. Bagchi, S. "Dengue bites India." Canadian Medical Association. Journal; CMAJ 180.7 (2009). Link to Full Text for this item Link to SFX for this item
15. Rivino, L. "Differential Targeting of Viral Components by CD4+ versus CD8+ T Lymphocytes in Dengue Infection." Journal of virology 87.5 (2012): 2693-2706. Link to Full Text for this item Link to SFX for this item
16. Williams, Katherine L. "Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo." Virology 429.1 (2012): 12-20. Link to SFX for this item
17. Osorio, Jorge E. "Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever." Vaccine 29.42 (2011): 7251-60. Link to SFX for this item
18. Gutsche, I. "Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein." Proceedings of the National Academy of Sciences of the United States of America 108.19 (2011): 8003-8. Link to Full Text for this item Link to SFX for this item
19. Capeding, Rosario Z. "Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines." Vaccine 29.22 (2011): 3863-3872. Link to SFX for this item
20. Lee, Sook a. "Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release." Journal of virology 84.10 (2010): 5171-80. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced